Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan

Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan ( Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan )
7 Oct 2013

FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA )
7 Oct 2013

Stem cell therapy for prevention of radiation-induced salivary gland toxicity

Dr Rob Coppes - University of Groningen, Netherlands
Stem cell therapy for prevention of radiation-induced salivary gland toxicity ( Dr Rob Coppes - University of Groningen, Netherlands )
7 Oct 2013

Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma

Dr Michele Maio - University Hospital of Siena, Siena, Italy
Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma ( Dr Michele Maio - University Hospital of Siena, Siena, Italy )
4 Oct 2013

Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
3 Oct 2013

Importance of the minimum data set in cancer nursing

Alessandra Milani - European Institute of Oncology, Milan, Italy
Importance of the minimum data set in cancer nursing ( Alessandra Milani - European Institute of Oncology, Milan, Italy )
3 Oct 2013

Analysis of progression free survival versus overall survival in melanoma

Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA
Analysis of progression free survival versus overall survival in melanoma ( Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2013

Prevention benefit from vitamin D

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Prevention benefit from vitamin D ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
3 Oct 2013

Advances in patient management through web and mobile based applications

Dr Yvonne Wengstrom - Karolinska Institute, Stockholm, Sweden
Advances in patient management through web and mobile based applications ( Dr Yvonne Wengstrom - Karolinska Institute, Stockholm, Sweden )
3 Oct 2013

Standardised and centralised care of sarcomas

Prof Ian Judson - Institute of Cancer Research, London, UK
Standardised and centralised care of sarcomas ( Prof Ian Judson - Institute of Cancer Research, London, UK )
3 Oct 2013

Biomarkers in the BOLERO3 trial

Prof Guy Jerusalem - Centre Hospitalier Universitaire du Sart-Tilman, Liège, Belgium
Biomarkers in the BOLERO3 trial ( Prof Guy Jerusalem - Centre Hospitalier Universitaire du Sart-Tilman, Liège, Belgium )
3 Oct 2013

Observational RASTER study on the 70-gene-signature

Dr Caroline Drukker - Netherlands Cancer Institute, Amsterdam
Observational RASTER study on the 70-gene-signature ( Dr Caroline Drukker - Netherlands Cancer Institute, Amsterdam )
3 Oct 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation